An update on human th1 and th2 cells

International Archives of Allergy and Immunology

Volumn 113, Issue 1-3, 1997, Pages 153-156

  Romagnani, S ^a   Parronchi, P ^a   D'Elios M M ^a   Romagnani, P ^a   Annunziato, F ^a   Piccinni, M P ^a   Manetti, R ^a   Sampognaro, S ^a   Mavilia, C ^a   De Carli, M ^a   Maggi, E ^a   Del Prete, G F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Allergy; Autoimmunity; Cytokines; Infections; Th1 Th2 cells

Indexed keywords

ALLERGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE;

ATOPY; AUTOIMMUNITY; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; ETIOLOGY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HELPER CELL; HOST RESISTANCE; HUMAN; IMMUNOPATHOLOGY; NEMATODE; PRIORITY JOURNAL; RECURRENT ABORTION; SCLEROSIS;

AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; HYPERSENSITIVITY; TH1 CELLS; TH2 CELLS;

EID: 8244249469     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237532     Document Type: Article

References (30)

1. Mosniann TR, Coffman RL: THI and TII2 cells: Different patterns of lymphokine secretion lead to different functional properties, An-nu Rev Immunol 1989;7:145-173.
2. Romagnani S: Lymphokine production by human T cells in disease states, Annu Rev Immunol 1994:12:227-257.
3. Romagnani S: Biology of human Thl and Th2 cells, J Clin ImmunoF 1995:15:121-129.
4. Del Prete G-F, De Carli M, Almerigogna F, Daniel KC, D'Elios MM, Zancuoghi D, Vinantc E, Pizzolo G, Romagnani S: Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines, FASEB J 1995:9:81-86.
5. Annunziato F, Manetti R, Tomasevic L, Giudizi M-G, Biagiotti R, Gianno V, Germano P, Mavi-lia C, Maggi E, Romagnani S: Expression and release of LAG-3-associated protein by human CD4+ T cells arc associated with IFN-y, FASEB J 1996;10:767-776.
6. Romagnani S: Induction of THI and TI12 response: A key role for the ‘natural' immune response? Immunol Today 1992:13:379-381.
7. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni M-P, Santoni Rugiu F, DeCarli M, Ricci M, Romagnani S: Reciprocal regulatory role of IFN-y and IL-4 on the in vitro development of human THI and TH2 clones, J Immunol 1992:148:2142-2147.
8. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni M-P, Macchia D, Maggi E, Romagnani S: IL-4 and IFNs (a and y) exert opposite regulatory effects on the development of cytolytic potential by Th 1 or Th2 human T cell clones, J Immunol 1992:149: 2977-2982.
9. Manetti R, Parronchi P, Giudizi M-G, Piccinni M-P, Maggi E, Trinchicri G, Romagnani S: Natural killer cell stimulatory factor (interleukin 12) induces T helper type 1 Thl specific immune responses and inhibits the development of IL-4-producing Th cells, J Exp Med 1993:177: 1199-1204.
10. Manctti R, Cicrosa F, Giudizi M-G, Biagiotti R, Parronchi P, Piccinni M-P, Sampognaro S, Mag-gi E, Romagnani S, Trinchieri G: Interleukin 12 induces stable priming for interferon y (IFN-y) production during differentiation of human T helper (Th) cells and transient IFN-y production in established Th2 cell clones, J Exp Med 1994:179:1273-1283.
11. Seder RA, Paul WE: Acquisition of lytnpho-kine-producing phenotype by CD4+ T cells, Annu Rev Immunol 1994:12:635-674.
12. Del Prete G-F, De Carli M, D'Elios MM, Daniel KC, Smith CA, Thomas E, Romagnani S: C'D30-mediatcd signalling promotes the development of human Th2-likc T cells, J Exp Med 1995;182:1-7.
13. Piccinni MP, Macchia D, Parronchi P, Giudizi M-G, Bani D, Alterini R, Grossi A, Ricci M, Maggi E, Romagnani S: Human bone marrow non-B, non-T cells produce interleukin 4 in response to cross-linkage of Fes and Fey receptors, Proc Natl Acad Sci USA 1991:88:8656-8660.
14. Bradding P, Feather III, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Hcusser CH, Bullock GR, Church MK, Holgate ST: Interleukin 4 is localized to and released by human mast cells, J Exp Med 1993;176:1381-1386.
15. Brunner T, Hcusser Cl, Dahinden CA: Human peripheral blood basophils primed by interleukin 3 (1L-3) produce 1L-4 in response to immunoglobulin E receptor stimulation, J Exp Med 1993;177:605-612.
16. Moqbcl R, Ying S, Barkans J, Newman TM, Kimmitt P, Vakelin M, Taborda-Barata L, Meng Q, Corrigan CJ, Durham SR, Kay AB: Identification of mRNA for interleukin 4 in human eosinophils with granule localization and release of the translated product, J Immunol, in press
17. Yoshimoto T, Paul WE: CD4+, NK1.1+ T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994: 179:1285-1295.
18. Kalinski P, Hilkens CMU, Wicrcnga EA, van Licr RAW, Bos JD, Kapsenbcrg ML, Snijdewint FGM: Functional maturation of human naive T helper cells in the absence of accessory cells, J Immunol 1995; 154:3753-3760.
19. Demeure CE, Yang L-P, Byun DG, Ishihara H, Vczzio N, Delespesse G: Human naive CD4 T cells produce interleukin-4 at priming and acquire a Th2 phenotype upon repetitive stimulations in neutral conditions, Eur J Immunol 1995;25:2722-2725.
20. Mingari M-C, Maggi E, Cambiaggi A, Annunziato F, Schiavetti F, Manetti R, Moretta L, Romagnani S: In vitro development of human CD4+ thymocytes into functionally mature Th2 cells, Exogenous IL-12 is required for priming thymocytes to the production of both Th 1 cytokines and IL-10. Eur J Immunol 1996;26:1083- 1087.
21. Romagnani S: Atopic allergy and other hypersensitivities, Technological advances and new insights in pathogenesis prelude to novel therapeutic strategics, C'urr Opin Immunol 1995:7: 745-750.
22. Piccinni MP, Beloni L, Giannarini L, Livi C, Scarselli GF, Romagnani S, Maggi E: Abnormal production ofTh2-type cytokines (IL-4 and IL-5) by T cells from newborns with atopic parents, Eur J Immunol, in press
23. Dc Carli M, DElios M, Mariotti S, Marcocci C, Pinchera A, Ricci M, Romagnani S, Del Prete GF: Cytolytic T cells with Th I-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves’ ophtalmopathy, J Clin Endocrinol Mctab 1993:77:1120-1124.
24. Brod SA, Benjamin D, Hafler DA: Restricted T cell expression of IL-2/IFN-y mRNA in human inflammatory disease, J Immunol 1991; 147:810-815.
25. Selmaj K, Rainc CS, Cannella B, Brosnan CF: Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions, J Clin Invest 1991;87:949-954.
26. Windliagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Hafler DA: Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86)and interleukin 12 cytokine:n multiple sclerosis lesions, J Exp Med 1995;182:1985-1996.
27. D’Elios MM, Manghetti M, Dc Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G-F: Till effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease, J Immunol 1997:158:962-967.
28. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S: Type 1 T helper cell predominance and IL-12 expression in the gut of patients with Crohn's disease, Amcr J Pathol 1997; 150: in press
29. Schandené L, Ferster A, Mascart-Lcmone F, Crusiaux A, Gerard C, Marchant A, Lybin M, Velu T, Sariban E, Goldman M: T helper type 2-like cells and therapeutic effects of interfc-ron-y in combined immunodeficiency with hy-pereosinophilia (Omenn’ssyndrome), EurJ Immunol 1993:23:56-60.
30. Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G-F, Almerigogna F, De Carli M, Pizzolo G: CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn’s syndrome, Evidence for a Th2-mcdi-ated condition, Eur J Immunol 1996;26:329-334